Delyon, Julie
Inserm · Assistance Publique – Hôpitaux de Paris · Hôpital Saint-Louis · Université Paris Diderot · HIPI - Immunologie humaine, physiopathologie et immunithérapie
3 papers on CoChatORCID 0000-0002-4557-3377
Most cited papers
- Verified
Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival
Delyon, J., Mateus, C., Lefeuvre, D., Lanoy, E., Zitvogel, L., Chaput, N., Roy, S., Eggermont, A. M. M., Routier, E., & Robert, C. (2013) · Annals of Oncology
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 318
- Verified
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors
Roger, A., Groh, M., Lorillon, G., Le Pendu, C., Maillet, J., Arangalage, D., Tazi, A., Lebbe, C., Baroudjian, B., & Delyon, J. (2019) · Annals of the Rheumatic Diseases
Vasculitis and related conditionsCancer Immunotherapy and Biomarkers
Cited by 39
- Verified
Checkpoint inhibitor treatment induces an increase in HbA1c in nondiabetic patients
Gauci, M.-L., Boudou, P., Squara, P.-A., Delyon, J., Allayous, C., Mourah, S., Resche-Rigon, M., Lebbé, C., Baroudjian, B., & Gautier, J.-F. (2019) · Melanoma Research
Cancer Immunotherapy and BiomarkersSkin Diseases and Diabetes
Cited by 10
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free